Top Clinical Trials companies in Italy by EPS (Diluted)

This ranking features the top 2 Clinical Trials companies in Italy ranked by EPS (Diluted), averaging a EPS (Diluted) of USD -0.58, for February 07, 2025.

Italy

Clinical Trials
EPS (Diluted)
#
Name
EPS (Diluted)
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
PHIL.MI

Philogen S.p.A.

1

PHIL.MI
USD -0.17
Dec. 31, 2023 USD 19.14 -0.29%

Italy
2
NP5.DE

Newron Pharmaceuticals S.p.A.

2

NP5.DE
USD -1.00
Dec. 31, 2023 USD 10.86 4.76%

Italy
Frequently Asked Questions
  • Which Clinical Trials company in Italy has the highest EPS (Diluted) ?

    The Clinical Trials company in Italy with the highest EPS (Diluted) is Philogen S.p.A. (Milan Stock Exchange: PHIL.MI) at USD -0.17.

  • Which Clinical Trials company in Italy has the lowest EPS (Diluted) ?

    The Clinical Trials company in Italy with the lowest EPS (Diluted) is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at USD -1.00.

SV Wall Street